Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
30 studies found for:    (menopause OR postmenopause) [CONDITION ] ((hormone therapy) OR HRT) [TREATMENT ] | Open Studies
Show Display Options
Rank Status Study
21 Not yet recruiting Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy
Conditions: Atrophic Vaginitis;   Menopause;   Vulvovaginal Atrophy
Intervention: Drug: Vaginal progesterone
22 Not yet recruiting Postprandial Lipidemia After a Meal With Different Types of Fat, Estrogen Treatment, Age and Gender in Healthy Subjects
Condition: Menopause
Interventions: Drug: Estrogens;   Other: Placebo
23 Unknown  Pituitary Derived-Intermedin is an Estrogen-Modulated Factor for Reducing Blood Pressure
Conditions: Menopause;   Hypertension
Intervention: Behavioral: intermedin
24 Not yet recruiting Phase I Clinical Trial of PK, PD and Safety Evaluations of Testosterone Gel 1% for 28 Days in Post-menopausal Women.
Condition: Post-menopausal Period
Intervention: Drug: Testosterone
25 Recruiting Tibolone and Placebo in Adjunct to Antidepressant Medication for Women With Menopausal Depression
Condition: Menopausal Depression
Intervention: Drug: Tibolone
26 Recruiting Estrogen and Serotonin on Changing Brain Chemistry
Condition: Menopause
Interventions: Drug: estradiol transdermal system;   Drug: Amino acid;   Drug: Placebo Patch;   Drug: Placebo
27 Recruiting CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Anastrozole or Letrozole or Exemestane
28 Recruiting Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women
Condition: Neoadjuvant Operable Breast Cancer
Interventions: Drug: Fluorouracile;   Drug: Epirubicin;   Drug: Cyclophosphamide;   Drug: Letrozole;   Drug: Palbociclib
29 Unknown  Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen
Conditions: Endometrial Hyperplasia;   Endometrial Cancer
Interventions: Drug: progesterone;   Drug: activella
30 Recruiting AKT Inhibitor in Oestrogen Positive Breast Cancer
Condition: Invasive Breast Cancer
Intervention: Drug: AZD5363

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-30) Next Page   
Indicates status has not been verified in more than two years